慢性疼痛患者中医疗大麻使用和医疗保健利用:使用TMLE的因果推理分析
Mitchell L Doucette1, Emily Fisher1, Junella Chin1
1Health Economics and Outcomes Research Department, Leafwell, Miami, FL 33156, USA.
Pharmacy (Basel, Switzerland)
|July 23, 2025
概括
慢性疼痛患者使用医用大麻与更少的紧急护理和急诊室访问有关. 这种疗法也改善了生活质量,每月减少了不健康的日子.
科学领域:
- 疼痛管理 疼痛管理
- 医学大麻研究 医学大麻研究
- 医疗保健服务研究 医疗服务研究
背景情况:
- 慢性疼痛影响了20%的美国成年人,造成了相当大的个人和医疗负担.
- 医用大麻是慢性疼痛的潜在疗法,但其对医疗保健使用的影响尚不清楚.
研究的目的:
- 调查慢性疼痛患者医用大麻使用与医疗保健利用之间的关联.
- 评估医用大麻对生活质量的影响.
主要方法:
- 一项回顾性队列研究,使用来自美国36个州的远程医疗平台行政数据.
- 患者分类为暴露于大麻 (在过去一年中使用) 或未暴露 (以前没有使用) 的患者.
- 结果:使用健康日措施的紧急护理,急诊室 (ED) 访问,住院和生活质量 (QoL). 通过目标最大概率估计估计的因果效应.
主要成果:
- 医用大麻使用者显著减少了医疗保健利用率.
- 与紧急护理访问减少2.0%和ED访问减少3.2%有关.
- 与每月不健康日减少3.5天有关;住院治疗的趋势较低,但不显著.
结论:
- 医用大麻使用与慢性疼痛患者医疗保健利用率下降有关.
- 医用大麻使用与这种人群中自我报告的改善生活质量有关.
相关概念视频
01:25Analgesia and Pain Management
809
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
809
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
369
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
369